Citation: Am. Damiano et al., THE HEALTH-RELATED QUALITY-OF-LIFE OF ADULTS WITH GAUCHERS-DISEASE RECEIVING ENZYME REPLACEMENT THERAPY - RESULTS FROM A RETROSPECTIVE STUDY, Quality of life research, 7(5), 1998, pp. 373-386
Citation: J. Charrow et al., GAUCHER-DISEASE - RECOMMENDATIONS ON DIAGNOSIS, EVALUATION, AND MONITORING, Archives of internal medicine, 158(16), 1998, pp. 1754-1760
Authors:
HERMANN G
PASTORES GM
ABDELWAHAB IF
LORBERBOYM AM
Citation: G. Hermann et al., GAUCHER-DISEASE - ASSESSMENT OF SKELETAL INVOLVEMENT AND THERAPEUTIC RESPONSES TO ENZYME REPLACEMENT, Skeletal radiology, 26(12), 1997, pp. 687-696
Authors:
LORBERBOYM M
PASTORES GM
KIM CK
HERMANN G
GLAJCHEN N
MACHAC J
Citation: M. Lorberboym et al., SCINTIGRAPHIC MONITORING OF RETICULOENDOTHELIAL SYSTEM IN PATIENTS WITH TYPE-1 GAUCHER-DISEASE ON ENZYME REPLACEMENT THERAPY, The Journal of nuclear medicine, 38(6), 1997, pp. 890-895
Citation: Me. Grace et al., IDENTIFICATION AND EXPRESSION OF ACID BETA-GLUCOSIDASE MUTATIONS CAUSING SEVERE TYPE-1 AND NEUROLOGIC TYPE-2 GAUCHER-DISEASE IN NON-JEWISH PATIENTS, The Journal of clinical investigation, 99(10), 1997, pp. 2530-2537
Citation: Gm. Pastores et al., LIPOPROTEIN METABOLISM IN TYPE-1 GAUCHER DISEASE PATIENTS ON ENZYME THERAPY, Journal of investigative medicine, 44(3), 1996, pp. 225-225
Authors:
PASTORES GM
HERMANN G
NORTON KI
LORBERBOYM M
DESNICK RJ
Citation: Gm. Pastores et al., REGRESSION OF SKELETAL CHANGES IN TYPE-1 GAUCHER DISEASE WITH ENZYME REPLACEMENT THERAPY, Skeletal radiology, 25(5), 1996, pp. 485-488
Authors:
FARAHATI J
TRENN G
JOHNMIKOLAJEWSKI V
ZANDER C
PASTORES GM
SCIUK J
REINERS C
Citation: J. Farahati et al., USE OF VARIOUS DIAGNOSTIC METHODS IN A PATIENT WITH GAUCHER DISEASE TYPE-I, Clinical nuclear medicine, 21(8), 1996, pp. 619-625
Authors:
MCCABE ERB
FINE BA
GOLBUS MS
GREENHOUSE JB
MCGRATH GL
NEW M
OBRIEN WE
ROWLEY PT
SLY WS
SPENCE MA
STOCKMAN JA
WHYTE M
WILSON W
WOLF B
AERTS JMFG
BARRANGER JA
BARTON NW
BEUTLER E
BRADY RO
COX TM
EKSTEIN J
ENG CM
ERIKSON A
FINDLING DM
GARBER AM
GINNS EI
GRABOWSKI GA
HILL SC
HOLLACK CEM
KABACK MM
LEE RE
MANKIN HJ
MISTRY PK
MOSCICKI RA
MURRAY GJ
NATOWICZ M
PASTORES GM
MIRANDA MCS
SIDRANSKY E
WARE JE
WILLEMSEN R
ZAIZOV R
ZIMRAN A
BEITINS IZ
BERMAN RE
ELLIOTT JM
FERGUSON JH
HALL WH
MCKEON C
NITKIN RM
SCHLESINGER SL
SHERIDAN PH
WEEKS M
COWDRY RW
ALEXANDER DF
GORDEN P
HALL ZW
VAITUKAITIS JL
COLLINS FS
GROFT S
Citation: Erb. Mccabe et al., GAUCHER DISEASE - CURRENT ISSUES IN DIAGNOSIS AND TREATMENT, JAMA, the journal of the American Medical Association, 275(7), 1996, pp. 548-553
Authors:
PASTORES GM
HERMANN G
NORTON K
DESNICK RJ
Citation: Gm. Pastores et al., RESOLUTION OF A PROXIMAL HUMERAL DEFECT IN TYPE-1 GAUCHER DISEASE BY ENZYME REPLACEMENT THERAPY, Pediatric radiology, 25(6), 1995, pp. 486-487
Citation: Ec. Miller et al., IDENTIFICATION AND EXPRESSION OF RARE MUTATIONS IN ACID BETA-GLUCOSIDASE CAUSING TYPE-1 AND TYPE-2 GAUCHER-DISEASE IN NON-JEWISH PATIENTS, American journal of human genetics, 57(4), 1995, pp. 1426-1426
Authors:
PASTORES GM
SANTORELLI FM
SHANSKE S
GELB BD
FYFE B
WOLFE D
WILLNER JP
Citation: Gm. Pastores et al., LEIGH-SYNDROME AND HYPERTROPHIC CARDIOMYOPATHY IN AN INFANT WITH A MITOCHONDRIAL-DNA POINT MUTATION (T8993G), American journal of medical genetics, 50(3), 1994, pp. 265-271
Citation: Jip. Calvo et Gm. Pastores, THE TREATMENT OF GAUCHER DISEASE TYPE-1 - TOWARDS A DEFINITIVE SOLUTION, Medicina Clinica, 103(1), 1994, pp. 16-18
Authors:
OLSON TM
MICHELS VV
LINDOR NM
PASTORES GM
WEBER JL
SCHAID DJ
DRISCOLL DJ
FELDT RH
THIBODEAU SN
Citation: Tm. Olson et al., AUTOSOMAL-DOMINANT SUPRAVALVULAR AORTIC-STENOSIS - LOCALIZATION TO CHROMOSOME-7, Human molecular genetics, 2(7), 1993, pp. 869-873
Citation: Gm. Pastores et al., ENZYME THERAPY IN GAUCHER DISEASE TYPE-1 - DOSAGE EFFICACY AND ADVERSE-EFFECTS IN 33 PATIENTS TREATED FOR 6 TO 24 MONTHS, Blood, 82(2), 1993, pp. 408-416